AOP Health signed an agreement with Leukos Biotech for the further development of a newly discovered chemical substance. With this agreement AOP Health expands the hemato-oncology research area even further and provides additional treatment options for certain leukemia patients in the longer term. Agnes Kohl, Chief Business Officer, AOP Orphan
WALTHAM, Mass and SHANGHAI, China, July 31, 2022 (GLOBE NEWSWIRE) — Zenas BioPharma, a global biopharmaceutical company committed to becoming a leader in the development and commercialization of immune-based therapies for patients in need around the world, announced that it has received approval of its Investigational New Drug (IND) application
A Japanese video journalist has been detained by security forces in Myanmar while covering a protest of military rule in the country’s largest city, pro-democracy activists said Sunday.Toru Kubota, a Tokyo-based documentary filmmaker, was arrested on S…
Kenyan ministers said the government has no intention of banning Facebook despite a watchdog last week accusing the social media platform of failing to stop hate speech ahead of Aug. 9 elections.Kenya’s National Cohesion and Integration Commission (NCI…
New York City Mayor Eric Adams declared a state of emergency Monday over the spread of monkeypox.“This order will bolster our existing efforts to educate, vaccinate, test, and treat as many New Yorkers as possible and ensure a whole-of-government respo…
The head of Myanmar’s junta, Min Aung Hlaing, will extend the state of emergency in the country for a further six months, state media said on Monday, reporting that the junta’s national defense and security council had given its approval.The junta firs…
SEOUL, South Korean shares shot up over 2 percent Tuesday as investors were buoyed by growing hopes that the U.S. Federal Reserve may carry out rate cuts this year.